We are excited to announce the availability of a brand-new, no-cost Afib Master Class with afib expert Dr. Eric Prystowsky. Dr. Prystowsky will be a faculty member once again at our upcoming annual Get in Rhythm. Stay in Rhythm.® Atrial Fibrillation Patient Conference. The master class comprises 33 short videos, in which Dr. Prystowsky provides …
Read More
In his talk about Treating Afib with Medications at the 2015 Get in Rhythm, Stay in Rhythm National Atrial Fibrillation Patient Conference, Dr. Mintu Turakhia of Stanford University covered many of the issues related to rate control and rhythm control medications and afib and heart failure. Access Dr. Turakhia’s talk at: Video: Treating Atrial Fibrillation …
Read More
Today, at the European Society of Cardiology Congress in Barcelona, it was reported that even though 80% of atrial fibrillation patients who should be on anticoagulants (according to their CHA2DS2-VASc score) are on anticoagulants, death rates at one year are still high. Most of those deaths are due to cardiovascular causes. The risk factors predicting …
Read More
Our January EP Lab Digest Patient Perspective column, Stuck in the Middle: Afib Patients on Rate Control, focuses on how rate control treatment (such as beta blockers) alone impacts the quality of life of those living with atrial fibrillation. The column also explores things doctors and patients may wish to consider in determining an appropriate …
Read More
A study presented at the recent American College of Cardiology Scientific Sessions by Dr. Matthew Reynolds of the Harvard Clinical Research Institute showed that having a radiofrequency (RF) catheter ablation for atrial fibrillation could reduce the risk of stroke by 40% compared to those who did not have an ablation. To learn more, see: Radiofrequency …
Read More
In this video interview, Emelia Benjamin, MD, professor of medicine and epidemiology at Boston University and senior investigator for the Framingham Heart Study, discusses atrial fibrillation risk factors and afib prevention, including the role of family history. She talks about the Framingham Risk Prediction Tool for Atrial Fibrillation and discusses well-known risks, such as advancing …
Read More
A new study reports that blood levels of a protein hormone called N-terminal pro-B-type natriuretic peptide (NT-proBNP) predicts new atrial fibrillation, regardless of other afib risk factors. Those with the highest levels were four times as likely to develop afib as those with the lowest levels. In the study, elevated levels of NT-proBNP occurred as …
Read More
Sleep apnea is an important risk factor for atrial fibrillation. It is also associated with hypertension, coronary artery disease, heart failure, stroke, diabetes, and insulin resistance, all of which are risk factors for, or results of, atrial fibrillation. Now a new study has just reported that men between the ages of 40 and 70 who …
Read More
A new study just published in the Archives of Internal Medicine showed that increasing severity of sleep apnea is associated with a progressively increasing risk of atrial fibrillation and ventricular arrhythmias. The type of sleep apnea matters: Obstructive sleep apnea is associated with an increased risk of ventricular events Central sleep apnea is common in heart …
Read More
The "Out of Sync: The State of Afib in America" survey compared the perspectives of patients who have been diagnosed with afib, and the physicians and nurses who treat afib patients. The results revealed a clear disconnect between medical professionals and patients about their understanding of afib risks. According to the survey: Less than half …
Read More